HUP0105308A2 - Eletriptán-hidrobromid-monohidrát, eljárás az előállítására és a vegyületet tartalmazó gyógyszerkészítmények - Google Patents

Eletriptán-hidrobromid-monohidrát, eljárás az előállítására és a vegyületet tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0105308A2
HUP0105308A2 HU0105308A HUP0105308A HUP0105308A2 HU P0105308 A2 HUP0105308 A2 HU P0105308A2 HU 0105308 A HU0105308 A HU 0105308A HU P0105308 A HUP0105308 A HU P0105308A HU P0105308 A2 HUP0105308 A2 HU P0105308A2
Authority
HU
Hungary
Prior art keywords
preparation
same
pharmaceutical compositions
compositions containing
eletriptan hydrobromide
Prior art date
Application number
HU0105308A
Other languages
English (en)
Inventor
Christopher Ian Dallman
Ronald James Ogilvie
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of HUP0105308A2 publication Critical patent/HUP0105308A2/hu
Publication of HUP0105308A3 publication Critical patent/HUP0105308A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

A találmány tárgya eletriptán-hidrobromid-monohidrát. A találmány az(1) képletű eletriptán-hidrobromid monohidrátra vonatkozik. Kiterjedtovábbá a találmány a vegyület előállítására, alkalmazására és amonohidrátot tartalmazó készítményekre. Ó
HU0105308A 1998-11-27 1999-11-01 Eletriptan hydrobromide monohydrate, process for its preparation and pharmaceutical compositions containing the same HUP0105308A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9825988.0A GB9825988D0 (en) 1998-11-27 1998-11-27 Indole derivatives

Publications (2)

Publication Number Publication Date
HUP0105308A2 true HUP0105308A2 (hu) 2002-05-29
HUP0105308A3 HUP0105308A3 (en) 2003-01-28

Family

ID=10843140

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0105308A HUP0105308A3 (en) 1998-11-27 1999-11-01 Eletriptan hydrobromide monohydrate, process for its preparation and pharmaceutical compositions containing the same

Country Status (53)

Country Link
US (2) US20020013358A1 (hu)
EP (1) EP1135381B1 (hu)
JP (1) JP3777094B2 (hu)
KR (1) KR100413739B1 (hu)
CN (1) CN1131860C (hu)
AP (1) AP2001002149A0 (hu)
AR (1) AR024232A1 (hu)
AT (1) ATE273300T1 (hu)
AU (1) AU754731B2 (hu)
BG (1) BG64706B1 (hu)
BR (1) BR9915692A (hu)
CA (1) CA2352392C (hu)
CO (1) CO5150178A1 (hu)
CR (1) CR6325A (hu)
CU (1) CU23269A3 (hu)
CZ (1) CZ295472B6 (hu)
DE (1) DE69919388T2 (hu)
DK (1) DK1135381T3 (hu)
DZ (1) DZ2948A1 (hu)
EA (1) EA003551B1 (hu)
EE (1) EE04914B1 (hu)
ES (1) ES2224701T3 (hu)
GB (1) GB9825988D0 (hu)
GC (1) GC0000113A (hu)
GE (1) GEP20043183B (hu)
GT (1) GT199900202A (hu)
HK (1) HK1042898B (hu)
HN (1) HN1999000196A (hu)
HR (1) HRP20010398B1 (hu)
HU (1) HUP0105308A3 (hu)
ID (1) ID28802A (hu)
IL (1) IL141663A (hu)
IS (1) IS2238B (hu)
MA (1) MA26708A1 (hu)
MY (1) MY124078A (hu)
NO (1) NO320798B1 (hu)
NZ (1) NZ510055A (hu)
OA (1) OA11671A (hu)
PA (1) PA8485701A1 (hu)
PE (1) PE20001299A1 (hu)
PL (1) PL194503B1 (hu)
PT (1) PT1135381E (hu)
RS (1) RS50002B (hu)
SI (1) SI1135381T1 (hu)
SK (1) SK285774B6 (hu)
SV (1) SV1999000204A (hu)
TN (1) TNSN99221A1 (hu)
TR (1) TR200101493T2 (hu)
TW (1) TWI246512B (hu)
UA (1) UA68402C2 (hu)
UY (2) UY25823A1 (hu)
WO (1) WO2000032589A1 (hu)
ZA (1) ZA200102681B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
WO2004089365A1 (en) 2003-04-11 2004-10-21 Pfizer Limited Pharmaceutical combination comprising eletriptan and sodium bicarbonate
GB0317229D0 (en) * 2003-07-23 2003-08-27 Pfizer Ltd Improved process
US6927296B2 (en) 2003-07-23 2005-08-09 Pfizer Inc. Process
WO2008137134A2 (en) * 2007-05-01 2008-11-13 Teva Pharmaceuticals Usa, Inc. Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
WO2008150500A1 (en) * 2007-05-29 2008-12-11 Plus Chemicals, S.A. A process for preparing 5-bromo-3-[(r)-1-methyl-pyrrolidin-2-ylmethyl]-1h-indole
US20100285075A1 (en) * 2007-12-17 2010-11-11 Actavis Group Ptc Ehf Novel Hemioxalate Salt of Eletriptan
WO2010097703A1 (en) * 2009-02-25 2010-09-02 Actavis Group Ptc Ehf Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity
WO2010116386A2 (en) * 2009-04-08 2010-10-14 Biophore India Pharmaceuticals Pvt. Ltd. Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
WO2011089614A1 (en) * 2010-01-19 2011-07-28 Sms Pharmaceuticals Limited PROCESS FOR PREPARING ELETRIPTAN HYDROBROMIDE HAVING α-FORM
WO2014063752A1 (en) 2012-10-26 2014-05-01 Synthon Bv Process for making crystalline form alpha of eletriptan hydrobromide
CN103893112A (zh) * 2012-12-31 2014-07-02 重庆圣华曦药业股份有限公司 氢溴酸依来曲普坦注射液
CN107954947A (zh) * 2016-10-14 2018-04-24 北京莱瑞森医药科技有限公司 沃替西汀氢溴酸盐晶型c及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
US5474784A (en) * 1990-03-02 1995-12-12 British Technology Group Limited Dispensing device
HU225055B1 (en) 1990-10-15 2006-05-29 Pfizer Indole derivatives, their intermediates, process for production them and pharmaceutical compositions containing the compounds
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5464633A (en) * 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9510223D0 (en) * 1995-05-20 1995-07-19 Pfizer Ltd Therapeutic agent
TW448172B (en) * 1996-03-08 2001-08-01 Pharmacia & Upjohn Co Llc Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation
US5998462A (en) * 1996-12-16 1999-12-07 Allelix Biopharmaceuticals Inc. 5-alkyl indole compounds
GB9704498D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Chemical compound
JP3350061B2 (ja) 1997-07-03 2002-11-25 ファイザー・インク エレトリプタンヘミスルフェートおよびカフェインを含有する医薬組成物

Also Published As

Publication number Publication date
PL194503B1 (pl) 2007-06-29
CR6325A (hu) 2008-07-02
CZ20011839A3 (cs) 2001-10-17
IS2238B (is) 2007-05-15
UY25823A1 (es) 2001-08-27
IS5868A (is) 2001-02-27
KR20010080594A (ko) 2001-08-22
US20020013358A1 (en) 2002-01-31
HRP20010398A2 (en) 2002-06-30
CN1328554A (zh) 2001-12-26
WO2000032589A1 (en) 2000-06-08
EE200100285A (et) 2002-08-15
EA003551B1 (ru) 2003-06-26
EE04914B1 (et) 2007-10-15
PT1135381E (pt) 2004-10-29
PL347928A1 (en) 2002-04-22
DE69919388T2 (de) 2005-09-29
ES2224701T3 (es) 2005-03-01
AU754731B2 (en) 2002-11-21
CZ295472B6 (cs) 2005-08-17
ZA200102681B (en) 2002-07-02
UY25825A1 (es) 2000-08-21
EA200100297A1 (ru) 2001-08-27
AU6225399A (en) 2000-06-19
DK1135381T3 (da) 2004-11-15
GT199900202A (es) 2001-05-19
AP2001002149A0 (en) 2001-06-30
UA68402C2 (en) 2004-08-16
YU18801A (sh) 2003-07-07
RS50002B (sr) 2008-09-29
TWI246512B (en) 2006-01-01
SK285774B6 (sk) 2007-08-02
GB9825988D0 (en) 1999-01-20
US20050131237A1 (en) 2005-06-16
SI1135381T1 (en) 2004-10-31
GEP20043183B (en) 2004-02-25
CN1131860C (zh) 2003-12-24
DE69919388D1 (de) 2004-09-16
NO20012584D0 (no) 2001-05-25
BR9915692A (pt) 2001-08-14
ATE273300T1 (de) 2004-08-15
NO20012584L (no) 2001-07-27
SV1999000204A (es) 2000-10-16
HK1042898B (zh) 2004-10-08
MA26708A1 (fr) 2004-12-20
KR100413739B1 (ko) 2004-01-03
MY124078A (en) 2006-06-30
AR024232A1 (es) 2002-09-25
BG64706B1 (bg) 2005-12-30
PE20001299A1 (es) 2000-12-01
EP1135381B1 (en) 2004-08-11
GC0000113A (en) 2005-06-29
NZ510055A (en) 2004-11-26
TR200101493T2 (tr) 2002-02-21
HK1042898A1 (en) 2002-08-30
HN1999000196A (es) 2005-11-26
NO320798B1 (no) 2006-01-30
DZ2948A1 (fr) 2004-03-15
BG105539A (en) 2001-12-29
TNSN99221A1 (fr) 2005-11-10
HUP0105308A3 (en) 2003-01-28
JP3777094B2 (ja) 2006-05-24
JP2002531449A (ja) 2002-09-24
SK6992001A3 (en) 2002-01-07
CO5150178A1 (es) 2002-04-29
CU23269A3 (es) 2008-04-09
IL141663A0 (en) 2002-03-10
CA2352392A1 (en) 2000-06-08
OA11671A (en) 2005-01-12
PA8485701A1 (es) 2000-09-29
US7238723B2 (en) 2007-07-03
ID28802A (id) 2001-07-05
EP1135381A1 (en) 2001-09-26
IL141663A (en) 2004-05-12
HRP20010398B1 (en) 2004-12-31
CA2352392C (en) 2006-01-24

Similar Documents

Publication Publication Date Title
HUP0400636A2 (hu) Azetidinszármazékokat tartalmazó gyógyszerkészítmények, új azetidinszármazékok és előállításuk
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
MY127718A (en) Dolastatin 10 derivatives.
HUP0100156A2 (hu) Foszfolipáz-A2 inhibitor hatású indolszármazékok és alkalmazásuk gyógyászati készítmények előállítására
HUP0301842A2 (hu) Laktám vegyület, a vegyületet tartalmazó gyógyszerkészítmény és alkalmazása gyógyszerkészítmény elżállítására
NO930693D0 (no) Mometasonfuroatmonohydrat, fremgangsmaate for fremstillingav dette og farmasoeytiske preprater
HUP0102084A2 (hu) Kinolinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
RU2088589C1 (en) Derivatives of 17 beta-substituted-4-aza-5-5 alpha-androstane-3-ones, methods of synthesis of compounds, pharmaceutical composition, compound 4
HUP0103460A2 (hu) Vírusellenes hatású indolszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények
HUP0102813A2 (hu) Perindopril-terc-butil-amin-só új béta-kristályos formája, eljárás ennek előállítására és ezt tartalmazó gyógyászati készítmények
HUP9603237A2 (hu) (R)-(-)-2-{N-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzizotiazol-2-il)-butil]-amino-metil}-kromán kristályos hidrokloridja, eljárás előállítására és a vegyületeket tartalmazó gyógyszerkészítmények
CA2414018A1 (en) 2-aminocarbonyl-9h-purine derivatives
HUP9702345A2 (hu) 3-Hidroxi-piridin-2-karbonsav-amid-észter-származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0100669A2 (hu) Szerin proteázokat gátló peptidszármazékok és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
HUP0001293A1 (hu) Heterociklusos vegyületek és ezeket tartalmazó gyógyászati készítmények béta-amiloid-peptidek gátlására
BR9714358A (pt) Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
HUP0105308A2 (hu) Eletriptán-hidrobromid-monohidrát, eljárás az előállítására és a vegyületet tartalmazó gyógyszerkészítmények
HUP0402492A2 (hu) 5HT4 részleges agonistát tartalmazó gyógyszerkészítmények
HK1030604A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
HUP0102515A2 (hu) Ciklopeptidek, eljárás előállításukra, hatóanyagként azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
HUT52040A (en) Process for producing diaryl-derivatives and pharmaceutical compositions containing them
HUP0000960A2 (hu) Porlasztva szárított paroxetin-hidroklorid, ennek előállítása, alkalmazása és a vegyületet tartalmazó gyógyszerkészítmények
HUP0202803A2 (en) Titanium derived compounds, preparation and use thereof
AU2003271811A8 (en) Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same
HUP0202729A2 (hu) Ösztramusztin-foszfátot és aminosavakat tartalmazó, parenteralis felhasználásra szolgáló készítmények

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees